Clemens Warnke

Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation

Till F. M. Andlauer, Dorothea Buck, Gisela Antony et al. · Science Advances · 2016 · 164 citations · Full text

Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk

Mitja Mitrovič, Nikolaos A. Patsopoulos, Ashley Beecham et al. · Cell · 2018 · 153 citations · Full text

<scp>l</scp> -Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients

Nicholas Schwab, Tilman Schneider‐Hohendorf, Vilmos Posevitz et al. · Neurology · 2013 · 141 citations

Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis

Sargis Abrahamyan, Bettina Eberspächer, Muna‐Miriam Hoshi et al. · Journal of Neurology Neurosurgery & Psychiatry · 2020 · 108 citations · Full text

Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19

Leoni Rolfes, Marc Pawlitzki, Steffen Pfeuffer et al. · Neurology Neuroimmunology & Neuroinflammation · 2021 · 106 citations · Full text